70% less morphine after bypass surgery
In CABG patients, tPEMF was associated with roughly a 70% lower morphine-equivalent dose.
The finding
In the Baylor / DeBakey VA cardiac work, tPEMF was associated with roughly a 70% reduction in morphine-equivalent dose among coronary-bypass patients — an even larger opioid-sparing signal than in the original plastic-surgery trial.
Why the size of this matters
Cardiac patients are older, sicker, and more vulnerable to the sedation and respiratory effects of opioids. Cutting morphine requirement by that magnitude in this population is not a marginal comfort gain — it bears directly on the complications that keep cardiac patients in the hospital longer.
The study design
CABG patients represent one of the most opioid-intensive post-surgical populations in hospital medicine. Sternotomy pain is severe; patients are typically managed with IV opioid PCA (patient-controlled analgesia) or scheduled IV morphine in the immediate ICU period. The morphine-equivalent dose tracked in this study captures total opioid exposure across the inpatient stay. A 70% reduction in that metric in a population where opioids are nearly universal — and where the alternatives are limited by hemodynamic and respiratory constraints — is a clinically significant finding.
What this means in practice
Seventy percent less morphine after open-heart surgery translates to a patient who is more alert, breathing more effectively, and able to begin physical therapy sooner. Each of these is a direct discharge determinant: a patient who can ambulate and demonstrate adequate respiratory function is a patient who is ready to leave. The two-day shorter stay documented in the companion finding is the institutional expression of those individual clinical improvements.
Compared to the standard alternative
IV morphine PCA is the cornerstone of post-CABG pain management. Its risks in this population — respiratory depression, ileus, delirium, hemodynamic lability — are well-known but accepted as necessary evils. Regional anesthetic techniques (epidural, paravertebral block) reduce but do not eliminate opioid use and carry procedural risks. tPEMF adds an additional layer of opioid reduction with no procedural risk, no systemic exposure, and no interaction with cardiac medications — making it uniquely appropriate in a population where the pharmacologic options are constrained.
Sources
- Awad et al. — CABG tPEMF clinical study, morphine-equivalent dose
Related
Ready to put SofPulse to work?
SofPulse is available by prescription. Patients can order online and pay with pre-tax HSA/FSA dollars; clinicians can start prescribing in minutes.
For education only — not medical advice, and not a substitute for a clinician's judgment. SofPulse is available by prescription only. Reimbursement figures reflect the 2026 CMS Physician Fee Schedule and vary by locality, payer, and documentation.